ImpediMed Ltd
ASX:IPD
ImpediMed Ltd
ASX:IPD
Price:
0.079 AUD
Market Closed
Updated:
May 28, 2024
EV/S
Enterprise Value to Sales
Enterprise Value to Sales
11.8
Current
16.2
Median
2.5
Industry
Lower
than median
Higher
than industry value
Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.
EV/S
=11.8
Enterprise Value
/
123.9m
Revenue
10.5m
All Countries
| Market Cap | EV/S | ||||
|---|---|---|---|---|---|
| AU |
|
ImpediMed Ltd
ASX:IPD
|
159.8m AUD | 11.8 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
176.9B USD | 4.5 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
142B USD | 18.7 | |
| US |
|
Stryker Corp
NYSE:SYK
|
128.8B USD | 6.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
110.5B USD | 8 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
107.6B USD | 3.8 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
65.9B USD | 4 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
60.2B EUR | 3.3 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
52.3B USD | 8.3 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
50.4B USD | 13.2 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
360.9B CNY | 9.5 |
EV/S Forward Multiples
Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/S
10.8
2-Years Forward
EV/S
6.2
3-Years Forward
EV/S
3.6
You don't have any saved screeners yet
